SOUTHBOROUGH, Mass.–(BUSINESS WIRE)– #Biotech–Veristat (the “Company”), a science-first full-service CRO and consultancy that advances complex therapies through the drug development lifecycle to regulatory submission, announced today its intended acquisition of Certara’s Regulatory and Medical Writing business. The team that will join Veristat is known for its white-glove advisory services and deep expertise authoring clinical and non-clinical documents throughout the drug development lifecycle. The ac
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
